Former Roche Diagnostics CSO and Biocartis Co-Founder join Abionic

Please login or
register
06.12.2017
Gerd Grenner (Picture right) and Nader Donzel (Picture left)

Abionic SA, a developer of nanotechnology based rapid diagnostic solutions, announced today the appointment of two diagnostic industry experts, Dr. Gerd Grenner (Picture right) and Nader Donzel (Picture left), to its Board of Directors.

“As Abionic moves to its next stage of corporate development, Gerd Grenner’s and Nader Donzel’s knowledge and industry experience will prove invaluable,” stated Dr. Nicolas Durand, CEO of Abionic. “Gerd and Nader bring complimentary expertise from large diagnostics companies and start-ups that will support our goal to become a leading player in rapid, point of care diagnostics.”

Gerd Grenner, PhD, has more than 35 years’ experience in R&D management positions in medical diagnostics companies. He previously held several top management positions at Roche Diagnostics in Basel (Switzerland), including Chief Scientific Officer, Chief Technology Officer and Director, Global R&D. Before Roche, Dr. Grenner was Director of Research at Polaroid-Behring Diagnostics in Boston.

Nader Donzel started his career building full-fledged automated high-throughput screening systems for the pharmaceutical and biotechnology industries at Scitec Automation, a company he founded and later sold to Caliper Life Sciences. He then worked at Caliper Life Sciences in Boston, MA, holding several R&D and marketing positions, including worldwide marketing manager for its laboratory automation product line.

He then was co-founder and held several executive positions at Biocartis. As COO he transitioned the company from startup to pre-commercial stage, while leading the development of commercial product line between 2009 and 2011. Between 2011 and 2013 he finalized the development and started the commercialization of Biocartis’ multiplexed biomarkers analysis platform. During this phase Nader Donzel setup a supply agreement with contract manufacturing organization, recruited sales and after-sales support staff, built opportunities pipeline, and closed first sales. Since 2014, Mr. Donzel is general manager of Scitec Research SA, a private laboratory offering chemical analytical services.

“It is a privilege to join a company with such impressive accomplishments, both from a technology and corporate development standpoint,” stated Nader Donzel. “Abionic has all the ingredients to become a major worldwide player in rapid point-of-care diagnostics.”

(SK)

0Comments

More news about

Abionic SA

Company profiles on startup.ch

Abionic SA

rss